Search

everythinglearnresearchcommunity

for

Search:↓

Elevated luteinizing hormone contributes to female-pattern hair loss, and blocking certain channels may help prevent it.

Testosterone therapy may help women with low sexual desire after surgical menopause.

Uterine transplants for transgender women are feasible but need more research.

Hirsutism, excessive male-pattern hair in women, can be caused by high androgens or skin sensitivity, diagnosed by testosterone levels, and treated with hair removal and hormone therapy.

Male mice with FGF5 mutations grow longer hair than females.

Higher hormone levels may be linked to female hair loss.

Hirsutism significantly lowers the quality of life for Turkish women.

The consensus provided guidelines for treating the Female Athlete Triad and a system to decide when athletes can return to sports.

Inhibiting certain enzymes made female rats more sensitive to low-level pain.

Menopause can cause hair loss in women due to hormonal changes, affecting their well-being and quality of life.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

New method measures female hair loss: Female Pattern Hair Loss Severity Index (FPHL-SI).

Advancements in technology now allow better evaluation and treatment for women with common hair loss problem, androgenic alopecia.

Environmental and social factors greatly affect women's reproductive health.

Androgens, male hormones, play a role in both men and women's health, and testosterone therapy can help women with low levels, but it's not suitable for pregnant or lactating women, or those with certain conditions.

The girl's unexpected pubic hair growth led to a diagnosis different from complete androgen insensitivity syndrome.

The document likely discusses how to tell the difference between excessive hair growth and the development of male characteristics in women.

Men have higher COVID-19 mortality rates than women due to biological and lifestyle factors.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

Diffuse alopecia in women may be related to androgens and iron deficiency, and basic hormone and nutrient screening is useful.

Most transgender patients getting laser hair removal before gender-affirming surgery are already on hormone therapy, which might affect the hair removal process.

The book provides comprehensive treatment strategies for female hair loss.

Ferulic acid can reduce seizures and depression-like behaviors in catamenial epilepsy by balancing hormones and brain enzyme activity.

Genetics affect early female hair loss, severity depends on duration, and low ferritin levels not significant.

Eating disorders in gender dysphoria patients may be a coping mechanism for body image issues.

Hormone therapy affects cancer risks in transgender individuals differently than in cisgender people, and more research is needed to understand these risks and improve cancer screening guidelines.

Menopause-related hormonal changes affect hair but are not the only cause of hair changes in middle-aged women.

Care for gender-dysphoric Veterans can be improved with a consistent, team-based approach.